FILE:CVS/CVS-8K-20021030173201.txt.gz
EVENTS:	Financial statements and exhibits
TEXT:
ITEM: Financial statements and exhibits
- ------------------------------------------------------------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 30, 2002 CVS CORPORATION (Exact Name of Registrant as Specified in its Charter) --------------- DELAWARE 001-01011 050494040 -------- --------- --------- (State or other jurisdiction of (Commission File Number) (IRS Employer incorporation or organization) Identification No.) ONE CVS DRIVE WOONSOCKET, RHODE ISLAND 02895 ------------------------ ----- (Address of principal executive offices) (Zip Code) (401) 765-1500 (Registrant's telephone number, including area code) NOT APPLICABLE (Former name or former address, if changed since last report) - -------------------------------------------------------------------------------
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS (c) Exhibits 99 Press Release, dated October 30, 2002 of CVS Corporation
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CVS CORPORATION By: /s/ David B. Rickard ------------------------------------------ David B. Rickard Executive Vice President, Chief Financial Officer and Chief Administrative Officer Dated: October 30, 2002

EXHIBIT 99 Investor Contact: Nancy Christal Media Contact: Todd Andrews Vice President Director Investor Relations Corporate Communications (914) 722-4704 (401) 770-5717 CVS CORPORATION ANNOUNCES PRICING OF $300 MILLION PRIVATE PLACEMENT OF 3.875% UNSECURED 5-YEAR SENIOR NOTES WOONSOCKET, R.I. -- October 30, 2002 -- CVS Corporation (NYSE: CVS) announced today that it privately placed $300 million aggregate principal amount of 3.875% unsecured senior notes due 2007 with an original issue price of 99.44%. The private placement is expected to close on or about November 4, 2002. The proceeds from the sale of the notes will be used to repay commercial paper. The notes have not been registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.


